Pacific Biosciences Of California (PACB) Other Non-Current Assets (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Other Non-Current Assets of $1.6 million for Q1 2026, down 82.9% year-over-year from $9.2 million in Q1 2025, and up 2.55% quarter-over-quarter from $1.5 million in Q4 2025.
Pacific Biosciences Of California (PACB) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- In Q1 2026, Other Non-Current Assets fell 82.9% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.6 million (down 82.9% YoY), while the FY2025 annual figure was $1.5 million, changed 0.0% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $1.6 million, up from $1.5 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $13.3 million in Q1 2023, with the low at $1.5 million in Q4 2024.
- The 5-year median for Other Non-Current Assets is $5.0 million (2022), against an average of $6.2 million.
- The sharpest annual moves came in 2022 and 2026: Other Non-Current Assets surged 7335.82% in 2022, then tumbled 82.9% in 2026.
- Pacific Biosciences Of California's Other Non-Current Assets stood at $2.9 million in 2022, then fell by 17.11% to $2.4 million in 2023, then sank by 36.75% to $1.5 million in 2024, then changed by 0.0% to $1.5 million in 2025, then increased by 2.55% to $1.6 million in 2026.
- Business Quant data shows PACB's Other Non-Current Assets at $1.6 million in Q1 2026, $1.5 million in Q4 2025, and $8.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 3.23 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 616.40 Mn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 273.70 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 148.78 Mn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Pacific Biosciences Of California | 397.64 Mn | 160.77 Mn | 12.64 Mn | 13.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.49 Mn |
| Mar 31, 2026 | 1.57 Mn |
| Dec 31, 2025 | 1.53 Mn |
| Sep 30, 2025 | 8.78 Mn |
| Jun 30, 2025 | 9.01 Mn |
| Mar 31, 2025 | 9.19 Mn |
| Dec 31, 2024 | 1.53 Mn |
| Sep 30, 2024 | 9.50 Mn |
| Jun 30, 2024 | 9.79 Mn |
| Mar 31, 2024 | 10.12 Mn |
| Dec 31, 2023 | 2.42 Mn |
| Sep 30, 2023 | 13.00 Mn |
| Jun 30, 2023 | 2.42 Mn |
| Mar 31, 2023 | 13.32 Mn |
| Dec 31, 2022 | 2.92 Mn |
| Sep 30, 2022 | 2.92 Mn |
| Jun 30, 2022 | 2.92 Mn |
| Mar 31, 2022 | 4.98 Mn |
| Dec 31, 2021 | 1.17 Mn |
| Jun 30, 2021 | 3.00 Mn |